Please use this identifier to cite or link to this item: http://www.repositorio.ufop.br/handle/123456789/7841
Title: Therapeutic responses to different anti-Trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock.
Authors: Caldas, Sérgio
Caldas, Ivo Santana
Cecílio, Alzira Batista
Diniz, Lívia de Figueiredo
Silva, André Talvani Pedrosa da
Ribeiro, Isabela
Bahia, Maria Terezinha
Keywords: Chemotherapy
Inflammation
Posaconazole
Fexinidazole
Issue Date: 2014
Citation: CALDAS, S. et al. Therapeutic responses to different anti-Trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock. Parasitology, v. 141, p. 1628-1637, 2014. Disponível em: <https://goo.gl/oNhl1T>. Acesso em: 19 fev. 2017.
Abstract: upon mice infection with a benznidazole-resistant Trypanosoma cruzi strain in the pathological outcomes. Trypanosoma cruzi-infected mice were treated with different drugs and parasite clearance time was detected by blood and tissue qPCR, to determine the dynamic relationship between the efficacy of the treatments and the intensity of heart lesion/serum inflammatory mediators. Our results indicate that anti-T. cruzi treatments were able to reduce parasite replication and consequently induce immunomodulatory effects, where the degree of the immunopathology prevention was related to the time of parasite clearance induced by different treatments. Nevertheless, in benznidazole and posaconazole treatments, parasite rebounding was detected with parasitism reaching levels similar to infected and non-treated mice; the time for parasitic rebound being earlier among benznidazole-treated mice. In parallel, an increase of cardiac lesions and plasma chemokine levels was also detected and was more accentuated in benznidazole-treated animals. Interestingly, in the presence of parasitological cure (fexinidazole treatment), basal levels of these inflammatory mediators were evidenced as well as an absence of cardiac inflammation or fibrosis. Overall, our data indicate that all treatments have positive effects on the clinical evolution of T. cruzi infection, with success in preventing cardiac alterations being drug-dependent.
URI: http://www.repositorio.ufop.br/handle/123456789/7841
metadata.dc.identifier.uri2: https://goo.gl/oNhl1T
ISSN: 14698161
Appears in Collections:DECBI - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_TherapeuticResponseDifferent.pdf605,8 kBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.